COP Stock UPDATES Conocophillips (COP) 78.96 09/09/2014 19:4

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Conocophillips (COP) 78.96 $COP

3 Reasons ConocoPhillips' Stock Could Fall
Matt DiLallo, The Motley Fool - Motley Fool - Tue Sep 09, 10:22AM CDT
Source: ConocoPhillips.  ConocoPhillips was the very first oil stock I ever bought, and I continue to hold it to this day. As a long-term investor, I've certainly seen the stock rise and fall, sometimes rather dramatically. While I'm not worried...

Power Your Portfolio with These 3 Energy ETFs - ETF News And Commentary
Zacks Equity Research - ZACKS - Tue Sep 09, 9:00AM CDT
These energy ETFs could be solid choices for investors in the current market environment.

Critical Alerts For 3D Systems, ConocoPhillips, Verizon, Baidu and First Solar Released By InvestorsObserver
PR Newswire - Tue Sep 09, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for DDD, COP, VZ, BIDU and FSLR.

Why ConocoPhillips (COP) Stock is Up In Pre-Market Trading Today
at The Street - Tue Sep 09, 8:13AM CDT
ConocoPhillips (COP) stock is higher this morning after the oil and gas company was upgraded to 'neutral' from 'underperform' with a $90 price target at Bank of America (BAC).

SmarTrend Watching for Potential Rebound in Shares of ConocoPhillips After 1.64% Loss
Comtex SmarTrend(R) - Mon Sep 08, 3:52PM CDT
ConocoPhillips (NYSE:COP) traded in a range yesterday that spanned from a low of $78.66 to a high of $80.05. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $79.45 on volume of 6.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Is It Time to Buy Phillips 66 Stock?
Jason Hall, The Motley Fool - Motley Fool - Mon Sep 08, 11:19AM CDT
Since being spun off of ConocoPhillips in 2012, Phillips 66 stock has crushed the market: PSX Total Return Price data by YCharts There are probably two questions investors are asking today:  First, is the stock due for a pullback?...

Next Support Level for ConocoPhillips (COP) is $79.08
Comtex SmarTrend(R) - Mon Sep 08, 9:33AM CDT
Shares of ConocoPhillips (NYSE:COP) opened today below their pivot of $80.10 and have already reached the first level of support at $79.72. Investors may be interested in a cross of the next downside pivot targets of $79.08 and $78.06.

Settlement of Claims, Technology Deployment, and Technical Updates - Research Reports on ConocoPhillips, Dow, United Steel, Occidental and Valero
PR Newswire - Mon Sep 08, 7:40AM CDT
Today, Analysts Review released its research reports regarding ConocoPhillips (NYSE: COP), The Dow Chemical Company (NYSE: DOW), United States Steel Corporation (NYSE: X), Occidental Petroleum Corporation (NYSE: OXY) and Valero Energy Corporation (NYSE: VLO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6277-100free.

The 1 Peculiar Trait Shared by Warren Buffett's Energy Investments
Tyler Crowe, The Motley Fool - Motley Fool - Sun Sep 07, 1:07PM CDT
It's OK if you want to invest like this guy; we do, too. Anyone that wants to be taken seriously as an investor wants to be like Warren Buffett. We like to track every move that he makes in the portfolio of Berkshire Hathaway   to see what...

After a Tragic Year, Malaysia Has This Reason to Be Optimistic
Matt DiLallo, The Motley Fool - Motley Fool - Sun Sep 07, 10:12AM CDT
Source: Wikimedia Commons.   The mysterious and tragic disappearance of Malaysia Airlines Flight 370 this past March has riveted the world for months on end. With no real no closure expected until the plane is found, the tragedy has rocked...

Oil Exploration & Production ETFs: Leaders or Laggards? - ETF News And Commentary
Sweta Killa - ZACKS - Fri Sep 05, 1:00PM CDT
How will oil & gas exploration & production ETFs perform in the coming months.

23 Oil Industry Stocks to Consider for Your Stock Portfolio
at The Street - Thu Sep 04, 12:07PM CDT
Here are 23 oil industry stocks and companies that you can consider investing in.

Dicker and Link: Shell and Total Are the Best of the Oil Super Majors
at The Street - Thu Sep 04, 12:05PM CDT
Dan Dicker, senior energy contributor for TheStreet.com, talks with Stephanie Link, co-portfolio manager of Action Alerts PLUS, about the megacap oil companies.

3 Reasons Pioneer Natural Resources Stock Could Fall
Matt DiLallo, The Motley Fool - Motley Fool - Thu Sep 04, 8:24AM CDT
Courtesy of Pioneer Natural Resources, Sands Weems-Photographer Pioneer Natural Resources is up an impressive 595% over the past five years. That's a big gain to say the least as it trounces the overall market, which is up 95% over that same...

ConocoPhillips vs Royal Dutch Shell plc: Which Company Returns More to Its Stockholders?
Matt DiLallo, The Motley Fool - Motley Fool - Wed Sep 03, 10:52AM CDT
Source: Royal Dutch Shell Flickr Media Library .  We work hard for our money. That's why when we choose to invest our excess we want it working just as hard, if not harder, on our behalf. The sad reality is not all companies and the management...

Next Resistance Level for ConocoPhillips (COP) is $81.69
Comtex SmarTrend(R) - Wed Sep 03, 9:30AM CDT
Shares of ConocoPhillips (NYSE:COP) opened today above their pivot of $80.36 and have already reached the first level of resistance at $80.96. Should the shares continue to rise, the resistance pivots of $81.69 and $83.02 will be of interest.

ConocoPhillips Set to Possibly Rebound After Yesterday's Selloff of 1.23%
Comtex SmarTrend(R) - Tue Sep 02, 4:04PM CDT
ConocoPhillips (NYSE:COP) traded in a range yesterday that spanned from a low of $79.77 to a high of $81.10. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $80.54 on volume of 5.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

ConocoPhillips Gives Up Claims from Green Dragon for $40M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 2:40PM CDT
ConocoPhillips (COP) would receive $40 million as the final settlement to renounce all claims from Green Dragon on various proceedings in multiple jurisdictions.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

DEFSEC Completes 9-to-1 Share Consolidation

Updated Category News Views 0

DEFSEC Technologies Tightens the Belt So, DEFSEC Technologies just pulled off something that'll kick up dust among investors. A 9-to-1 share consolidation—now that's no small fry. For those riding the NASDAQ or the TSX Venture with a tight grip on their DEFSEC shares, it's strictly business today. Post-consolidation, DEFSEC's common shares are set to trade under the...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 177

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Gayatri Pariwar Celebrates 100 Years with Massive Yoga Event

Updated Category News Views 52

An Impressive Centenary for Gayatri Pariwar Sometimes, you get hit by a wave so big you can't ignore it, and Gayatri Pariwar's centennial festival in New Delhi was one such tsunami. Picture this: countless souls gathered to mark a hundred years of spiritual and social reform, not just with chants and talks, but through an awe-inspiring mass yoga event. In my decades...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 231

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 459

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 23

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
LongueVue Capital: Betting Big on Sports & Entertainment

Updated Category News Views 54

LongueVue Capital's Bold Move You don’t always hear about private equity firms diving head-first into the sports and entertainment sector, but LongueVue Capital (LVC) is doing just that. This New Orleans-based firm is shifting its gears and setting sights on founder-owned ventures crucial to these industries. They’re asking the key question: Why focus on just the...

Continue Reading
Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 46

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 373

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 142

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading

Top 5 Most Recently Viewed Articles

Insigneo Welcomes Esteban Diaz to Enhance Wealth Management

Updated Category News Views 159

Insigneo Strengthens Its Wealth Management Team Insigneo, a prominent name in wealth management, proudly announces the addition of Esteban Diaz as Senior Vice President. This significant recruitment is part of the firm’s ongoing commitment to enhancing its network, particularly in serving high-net-worth clients in the Latin American region. About Esteban Diaz's...

Continue Reading
Exploring RBC Bearings: A Five-Year Investment Journey

Updated Category News Views 172

RBC Bearings: A Strong Investment Over Time RBC Bearings has proven to be a formidable player in the market, showcasing impressive performance over the last five years. With an average annual return of 18.74%, any investment made during this period would have reaped considerable rewards. The Growth of a $1000 Investment Imagine if you had decided to invest $1000 in RBC...

Continue Reading
ANI Pharmaceuticals Enhances Ophthalmology Strategy with Experts

Updated Category News Views 227

ANI Pharmaceuticals Launches FutureVision Advisory Council In a strategic move to bolster its ophthalmology and retina franchise, ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) has established the FutureVision Advisory Council. This dedicated council aims to guide the ongoing innovations within ANI's Rare Disease portfolio, focusing particularly on ophthalmological care....

Continue Reading
Unlocking Financial Freedom: The CESUR Mining Game Changer

Updated Category News Views 99

Understanding CESUR Mining and Its Impact CESUR Mining is quickly becoming a significant player in the world of cryptocurrency. This innovative platform enables users to tap into the potential of cloud mining, allowing them to earn passive income without the need for technical knowledge or constant monitoring. Established with the vision to simplify the mining process,...

Continue Reading
Understanding Nvidia's Role in the S&P 500 Market Dynamics

Updated Category News Views 204

Nvidia's Influence on the S&P 500 Market The stock market can be quite a wild ride, with swings that can astonish even the most experienced investors. Recently, stocks started off relatively flat but soon encountered volatility, leading to a significant rally largely fueled by news surrounding Nvidia. This surge prompts important questions about how the S&P 500 will...

Continue Reading